Unresolved disorder model. using A ATOM 177 N AILE 22 7.678 4.023 23.658 0.50 11.75 N Unresolved disorder model. using A ATOM 178 N BILE 22 7.679 4.022 23.653 0.50 11.88 N Unresolved disorder model. using A ATOM 179 CA AILE 22 6.440 3.954 24.421 0.50 11.54 C Unresolved disorder model. using A ATOM 180 CA BILE 22 6.432 3.961 24.404 0.50 11.79 C Unresolved disorder model. using A ATOM 181 C AILE 22 5.839 2.549 24.330 0.50 10.80 C Unresolved disorder model. using A ATOM 182 C BILE 22 5.836 2.552 24.325 0.50 10.94 C Unresolved disorder model. using A ATOM 183 O AILE 22 4.891 2.224 25.043 0.50 10.56 O Unresolved disorder model. using A ATOM 184 O BILE 22 4.892 2.227 25.043 0.50 10.69 O Unresolved disorder model. using A ATOM 185 CB AILE 22 5.417 5.005 23.921 0.50 10.87 C Unresolved disorder model. using A ATOM 186 CB BILE 22 5.408 4.993 23.863 0.50 11.37 C Unresolved disorder model. using A ATOM 187 CG1AILE 22 4.344 5.235 24.988 0.50 11.37 C Unresolved disorder model. using A ATOM 188 CG1BILE 22 4.286 5.202 24.881 0.50 12.21 C Unresolved disorder model. using A ATOM 189 CG2AILE 22 4.789 4.544 22.612 0.50 10.82 C Unresolved disorder model. using A ATOM 190 CG2BILE 22 4.845 4.522 22.531 0.50 11.33 C Unresolved disorder model. using A ATOM 191 CD1AILE 22 3.390 6.365 24.665 0.50 12.35 C Unresolved disorder model. using A ATOM 192 CD1BILE 22 4.752 5.803 26.187 0.50 12.63 C Unresolved disorder model. using A ATOM 276 N AASP 34 -9.199 -10.449 31.607 0.50 8.03 N Unresolved disorder model. using A ATOM 277 N BASP 34 -9.190 -10.466 31.604 0.50 8.16 N Unresolved disorder model. using A ATOM 278 CA AASP 34 -9.489 -11.497 32.574 0.50 9.37 C Unresolved disorder model. using A ATOM 279 CA BASP 34 -9.493 -11.540 32.536 0.50 9.59 C Unresolved disorder model. using A ATOM 280 C AASP 34 -10.904 -11.196 33.056 0.50 9.41 C Unresolved disorder model. using A ATOM 281 C BASP 34 -10.889 -11.219 33.056 0.50 9.59 C Unresolved disorder model. using A ATOM 282 O AASP 34 -11.117 -10.282 33.852 0.50 10.16 O Unresolved disorder model. using A ATOM 283 O BASP 34 -11.071 -10.316 33.872 0.50 10.53 O Unresolved disorder model. using A ATOM 284 CB AASP 34 -8.484 -11.431 33.731 0.50 9.97 C Unresolved disorder model. using A ATOM 285 CB BASP 34 -8.469 -11.566 33.673 0.50 10.51 C Unresolved disorder model. using A ATOM 286 CG AASP 34 -8.794 -12.420 34.841 0.50 11.50 C Unresolved disorder model. using A ATOM 287 CG BASP 34 -8.653 -12.757 34.590 0.50 12.55 C Unresolved disorder model. using A ATOM 288 OD1AASP 34 -7.907 -12.653 35.688 0.50 12.56 O Unresolved disorder model. using A ATOM 289 OD1BASP 34 -9.560 -12.716 35.445 0.50 13.02 O Unresolved disorder model. using A ATOM 290 OD2AASP 34 -9.920 -12.957 34.876 0.50 12.01 O Unresolved disorder model. using A ATOM 291 OD2BASP 34 -7.896 -13.739 34.445 0.50 14.90 O Unresolved disorder model. using A ATOM 577 N AASP 71 -16.279 10.606 6.485 0.50 13.53 N Unresolved disorder model. using A ATOM 578 N BASP 71 -16.275 10.610 6.479 0.50 13.81 N Unresolved disorder model. using A ATOM 579 CA AASP 71 -16.208 12.057 6.455 0.50 14.19 C Unresolved disorder model. using A ATOM 580 CA BASP 71 -16.193 12.061 6.461 0.50 14.68 C Unresolved disorder model. using A ATOM 581 C AASP 71 -16.536 12.541 7.864 0.50 14.53 C Unresolved disorder model. using A ATOM 582 C BASP 71 -16.534 12.544 7.862 0.50 14.87 C Unresolved disorder model. using A ATOM 583 O AASP 71 -17.685 12.460 8.297 0.50 15.82 O Unresolved disorder model. using A ATOM 584 O BASP 71 -17.686 12.468 8.288 0.50 16.12 O Unresolved disorder model. using A ATOM 585 CB AASP 71 -17.233 12.612 5.465 0.50 15.06 C Unresolved disorder model. using A ATOM 586 CB BASP 71 -17.187 12.648 5.458 0.50 16.12 C Unresolved disorder model. using A ATOM 587 CG AASP 71 -17.153 14.117 5.327 0.50 15.64 C Unresolved disorder model. using A ATOM 588 CG BASP 71 -17.392 14.137 5.653 0.50 17.16 C Unresolved disorder model. using A ATOM 589 OD1AASP 71 -17.107 14.806 6.367 0.50 14.24 O Unresolved disorder model. using A ATOM 590 OD1BASP 71 -16.383 14.866 5.746 0.50 16.99 O Unresolved disorder model. using A ATOM 591 OD2AASP 71 -17.142 14.610 4.179 0.50 16.92 O Unresolved disorder model. using A ATOM 592 OD2BASP 71 -18.560 14.579 5.712 0.50 18.25 O Unresolved disorder model. using A ATOM 697 N ATHR 87 -18.413 13.858 23.317 0.50 15.32 N Unresolved disorder model. using A ATOM 698 N BTHR 87 -18.413 13.854 23.318 0.50 15.61 N Unresolved disorder model. using A ATOM 699 CA ATHR 87 -18.713 13.158 22.073 0.50 13.84 C Unresolved disorder model. using A ATOM 700 CA BTHR 87 -18.710 13.144 22.083 0.50 14.42 C Unresolved disorder model. using A ATOM 701 C ATHR 87 -17.463 12.810 21.271 0.50 12.63 C Unresolved disorder model. using A ATOM 702 C BTHR 87 -17.459 12.805 21.280 0.50 12.99 C Unresolved disorder model. using A ATOM 703 O ATHR 87 -16.553 13.627 21.131 0.50 12.27 O Unresolved disorder model. using A ATOM 704 O BTHR 87 -16.548 13.623 21.151 0.50 12.59 O Unresolved disorder model. using A ATOM 705 CB ATHR 87 -19.643 14.010 21.183 0.50 15.14 C Unresolved disorder model. using A ATOM 706 CB BTHR 87 -19.649 13.974 21.194 0.50 16.12 C Unresolved disorder model. using A ATOM 707 OG1ATHR 87 -20.832 14.335 21.913 0.50 17.40 O Unresolved disorder model. using A ATOM 708 OG1BTHR 87 -19.054 15.252 20.940 0.50 17.29 O Unresolved disorder model. using A ATOM 709 CG2ATHR 87 -20.021 13.254 19.915 0.50 14.58 C Unresolved disorder model. using A ATOM 710 CG2BTHR 87 -20.990 14.176 21.882 0.50 17.85 C Unresolved disorder model. using A ATOM 923 N ALYS 113 -8.141 -16.311 21.889 0.50 9.20 N Unresolved disorder model. using A ATOM 924 N BLYS 113 -8.147 -16.309 21.887 0.50 9.45 N Unresolved disorder model. using A ATOM 925 CA ALYS 113 -7.923 -15.477 20.711 0.50 9.00 C Unresolved disorder model. using A ATOM 926 CA BLYS 113 -7.926 -15.470 20.714 0.50 9.45 C Unresolved disorder model. using A ATOM 927 C ALYS 113 -9.054 -15.711 19.715 0.50 8.85 C Unresolved disorder model. using A ATOM 928 C BLYS 113 -9.038 -15.711 19.701 0.50 9.10 C Unresolved disorder model. using A ATOM 929 O ALYS 113 -9.423 -16.854 19.449 0.50 10.11 O Unresolved disorder model. using A ATOM 930 O BLYS 113 -9.377 -16.856 19.407 0.50 10.33 O Unresolved disorder model. using A ATOM 931 CB ALYS 113 -6.600 -15.837 20.025 0.50 9.20 C Unresolved disorder model. using A ATOM 932 CB BLYS 113 -6.581 -15.804 20.064 0.50 10.05 C Unresolved disorder model. using A ATOM 933 CG ALYS 113 -5.336 -15.509 20.802 0.50 7.78 C Unresolved disorder model. using A ATOM 934 CG BLYS 113 -5.372 -15.492 20.922 0.50 9.86 C Unresolved disorder model. using A ATOM 935 CD ALYS 113 -4.107 -15.899 19.986 0.50 10.13 C Unresolved disorder model. using A ATOM 936 CD BLYS 113 -4.098 -16.013 20.281 0.50 11.36 C Unresolved disorder model. using A ATOM 937 CE ALYS 113 -2.808 -15.487 20.662 0.50 9.89 C Unresolved disorder model. using A ATOM 938 CE BLYS 113 -2.873 -15.605 21.080 0.50 13.34 C Unresolved disorder model. using A ATOM 939 NZ ALYS 113 -2.551 -16.248 21.916 0.50 11.75 N Unresolved disorder model. using A ATOM 940 NZ BLYS 113 -1.624 -16.166 20.501 0.50 14.08 N Unresolved disorder model. using A ATOM 1229 N ASER 152 -21.531 -18.298 10.869 0.50 10.68 N Unresolved disorder model. using A ATOM 1230 N BSER 152 -21.535 -18.303 10.865 0.50 10.67 N Unresolved disorder model. using A ATOM 1231 CA ASER 152 -22.456 -17.778 9.869 0.50 11.42 C Unresolved disorder model. using A ATOM 1232 CA BSER 152 -22.450 -17.790 9.853 0.50 11.41 C Unresolved disorder model. using A ATOM 1233 C ASER 152 -21.887 -16.483 9.298 0.50 11.26 C Unresolved disorder model. using A ATOM 1234 C BSER 152 -21.875 -16.496 9.290 0.50 11.27 C Unresolved disorder model. using A ATOM 1235 O ASER 152 -21.153 -15.769 9.980 0.50 11.59 O Unresolved disorder model. using A ATOM 1236 O BSER 152 -21.125 -15.794 9.970 0.50 11.61 O Unresolved disorder model. using A ATOM 1237 CB ASER 152 -23.823 -17.501 10.501 0.50 12.51 C Unresolved disorder model. using A ATOM 1238 CB BSER 152 -23.825 -17.517 10.463 0.50 12.57 C Unresolved disorder model. using A ATOM 1239 OG ASER 152 -24.373 -18.679 11.066 0.50 14.13 O Unresolved disorder model. using A ATOM 1240 OG BSER 152 -23.754 -16.490 11.436 0.50 14.00 O Unresolved disorder model. using A ATOM 1337 N ASER 166 -10.045 -4.854 -5.295 0.50 18.08 N Unresolved disorder model. using A ATOM 1338 N BSER 166 -10.035 -4.848 -5.303 0.50 17.55 N Unresolved disorder model. using A ATOM 1339 CA ASER 166 -9.613 -3.605 -5.915 0.50 17.74 C Unresolved disorder model. using A ATOM 1340 CA BSER 166 -9.575 -3.620 -5.941 0.50 16.78 C Unresolved disorder model. using A ATOM 1341 C ASER 166 -8.513 -2.880 -5.145 0.50 16.93 C Unresolved disorder model. using A ATOM 1342 C BSER 166 -8.484 -2.896 -5.158 0.50 16.43 C Unresolved disorder model. using A ATOM 1343 O ASER 166 -7.949 -1.905 -5.638 0.50 17.29 O Unresolved disorder model. using A ATOM 1344 O BSER 166 -7.901 -1.933 -5.651 0.50 17.02 O Unresolved disorder model. using A ATOM 1345 CB ASER 166 -10.809 -2.666 -6.077 0.50 19.08 C Unresolved disorder model. using A ATOM 1346 CB BSER 166 -10.757 -2.673 -6.169 0.50 17.45 C Unresolved disorder model. using A ATOM 1347 OG ASER 166 -11.811 -3.240 -6.897 0.50 20.12 O Unresolved disorder model. using A ATOM 1348 OG BSER 166 -11.324 -2.240 -4.945 0.50 15.15 O Chain identifier should be blank not A: ATOM 2118 ZN ZN A 803 -6.602 -1.582 15.142 1.00 6.48 ZN 1